세계의 혈당 모니터링 기기 시장 : 유형, 용도, 최종 사용자별 예측(2025-2030년)

The Glucose Monitoring Devices Market was valued at USD 7.37 billion in 2023, expected to reach USD 8.26 billion in 2024, and is projected to grow at a CAGR of 12.43%, to USD 16.75 billion by 2030.

Glucose Monitoring Devices encompass tools that measure and provide real-time feedback on blood glucose levels, critical for managing diabetes. The necessity for these devices is driven by the rising incidence of diabetes globally, increased health awareness, and advancements in healthcare technology. Their application spans across continuous glucose monitors (CGMs), flash glucose monitors, and traditional self-monitoring blood glucose (SMBG) devices, primarily used by individuals with diabetes, hospitals, and clinics. The end-use scope includes personal use, hospital care, and ambulatory settings. Key growth influencers include the growing demand for remote diabetes monitoring and management solutions, technological advancements such as non-invasive and minimally invasive monitoring techniques, and increased healthcare spending. Potential opportunities involve the integration of artificial intelligence and machine learning for predictive analytics, enhancing user experience through smartphone app interfaces, and expanding into emerging markets where diabetes prevalence is rising. To capitalize on these opportunities, companies should focus on developing user-friendly devices with improved accuracy and reliability and expanding their distribution networks in developing regions. However, the market faces challenges such as stringent regulatory requirements, the high cost of advanced devices, and issues related to data privacy and handling, which can slow down adoption rates. Innovations are expected in areas like implantable sensors, closed-loop systems integrating insulin pumps with monitors, and the use of wearable technology for continuous monitoring. The market is dynamic with rapid technological advancements, offering significant scope for differentiation and growth to innovators who can address usability and affordability challenges. For business growth, companies should prioritize research into improving sensor accuracy, enhancing product design for ease of use, and ensuring compliance with global health and safety standards to gain a competitive edge in this highly potential and evolving market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Glucose Monitoring Devices Market

The Glucose Monitoring Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising cases of chronic disease across the globe
  • Surging regulatory approvals for glucose monitoring devices
  • Increasing need for home-based treatment and self-medication
• Market Restraints
  • Unfavorable reimbursement policies
• Market Opportunities
  • Technological advancements and excessive research & development
  • Rising preference for non-invasive methods
• Market Challenges
  • Lack of standardization

Porter's Five Forces: A Strategic Tool for Navigating the Glucose Monitoring Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Glucose Monitoring Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Glucose Monitoring Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Glucose Monitoring Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Glucose Monitoring Devices Market

A detailed market share analysis in the Glucose Monitoring Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Glucose Monitoring Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Glucose Monitoring Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Glucose Monitoring Devices Market

A strategic analysis of the Glucose Monitoring Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Glucose Monitoring Devices Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca Plc, B. Braun Melsungen AG, Bayer AG, Becton, Dickinson & Company, DexCom, Inc., GE Healthcare, GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Lupin Limited, Medtronic, Plc, Merck & Co., Inc., Nova Biomedical Corporation, Novartis AG, Omron Corporation, and ResMed Inc..

Market Segmentation & Coverage

This research report categorizes the Glucose Monitoring Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Diabetes Monitoring Devices and Insulin Delivery Devices. The Diabetes Monitoring Devices is further studied across Continuous Glucose Monitoring Devices, Glucose Meter, Glucose Test Strips, and Lancets & Lancing Devices. The Insulin Delivery Devices is further studied across Insulin Pens, Insulin Pumps, and Insulin Syringes.
• Based on Application, market is studied across Gestational Diabetes, Type 1 Diabetes, and Type 2 Diabetes.
• Based on End-User, market is studied across Diagnostics, Home Settings, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising cases of chronic disease across the globe
    • 5.1.1.2. Surging regulatory approvals for glucose monitoring devices
    • 5.1.1.3. Increasing need for home-based treatment and self-medication
  • 5.1.2. Restraints
    • 5.1.2.1. Unfavorable reimbursement policies
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements and excessive research & development
    • 5.1.3.2. Rising preference for non-invasive methods
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of standardization
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Glucose Monitoring Devices Market, by Type

• 6.1. Introduction
• 6.2. Diabetes Monitoring Devices
  • 6.2.1. Continuous Glucose Monitoring Devices
  • 6.2.2. Glucose Meter
  • 6.2.3. Glucose Test Strips
  • 6.2.4. Lancets & Lancing Devices
• 6.3. Insulin Delivery Devices
  • 6.3.1. Insulin Pens
  • 6.3.2. Insulin Pumps
  • 6.3.3. Insulin Syringes

7. Glucose Monitoring Devices Market, by Application

• 7.1. Introduction
• 7.2. Gestational Diabetes
• 7.3. Type 1 Diabetes
• 7.4. Type 2 Diabetes

8. Glucose Monitoring Devices Market, by End-User

• 8.1. Introduction
• 8.2. Diagnostics
• 8.3. Home Settings
• 8.4. Hospitals

9. Americas Glucose Monitoring Devices Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Glucose Monitoring Devices Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Glucose Monitoring Devices Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AstraZeneca Plc
• 2. B. Braun Melsungen AG
• 3. Bayer AG
• 4. Becton, Dickinson & Company
• 5. DexCom, Inc.
• 6. GE Healthcare
• 7. GlaxoSmithKline PLC
• 8. Johnson & Johnson Services, Inc.
• 9. Koninklijke Philips N.V.
• 10. Lupin Limited
• 11. Medtronic, Plc
• 12. Merck & Co., Inc.
• 13. Nova Biomedical Corporation
• 14. Novartis AG
• 15. Omron Corporation
• 16. ResMed Inc.